Boehringer Ingelheim

PharmaceuticalBiotechnologyMedicalHealth Care
Website LinkedIn Email Phone # Facebook Twitter

Boehringer Ingelheim is a research-driven pharmaceutical company dedicated to improving health and quality of life through innovative research, development, manufacturing, and marketing of its products.

Related companies:

🏢 Amgen
💰 $28.5B Post-IPO Debt on 2022-12-12🫂 on 2023-10-24Biotechnology Research
Website LinkedIn Email Phone # Facebook Twitter